Literature DB >> 4701794

A trial of prophylactic replacement therapy in haemophilia and Christmas disease.

D M Ramsay, A C Parker.   

Abstract

A trial of prophylactic replacement therapy in low dosage once a week is described in two patients with classical haemophilia and one patient with Christmas disease, using concentrates of factor VIII and factor IX respectively. The clinical effectiveness and complications of the therapy are assessed and discussed. It was concluded that the patient suffering from Christmas disease showed both objective and subjective improvement while on prophylaxis and merited further study. Neither of the patients with haemophilia showed objective evidence of improvement, but both stated that they felt fitter and more able to lead a normal life while on the trial.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4701794      PMCID: PMC477696          DOI: 10.1136/jcp.26.4.243

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE.

Authors:  J G POOL; E J GERSHGOLD; A R PAPPENHAGEN
Journal:  Nature       Date:  1964-07-18       Impact factor: 49.962

2.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

3.  Severe reactions after cryoprecipitated human factor VIII.

Authors:  S Ahrons; S Glavind-Kristensen; O Drachmann; F Kissmeyer-Nielsen
Journal:  Vox Sang       Date:  1970-02       Impact factor: 2.144

4.  Dental extractions and the use of Christmas factor concentrate in cases of haemophilia B.

Authors:  S Van Creveld; R Buchner
Journal:  Vox Sang       Date:  1970-05       Impact factor: 2.144

5.  Prophylactic treatment of factor VIII deficiency.

Authors:  R J Hirschman; S B Itscoitz; N R Shulman
Journal:  Blood       Date:  1970-02       Impact factor: 22.113

6.  Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.

Authors:  E Shanbrom; G M Thelin
Journal:  JAMA       Date:  1969-06-09       Impact factor: 56.272

7.  Preparation and clinical use of factor IX concentrate PPSB according to Soulier.

Authors:  C Haanen; R L McShine; A Kunst
Journal:  Vox Sang       Date:  1969-04       Impact factor: 2.144

8.  A clinical and experimental study of acquired inhibitors to factor 8.

Authors:  H R Roberts; M B Scales; J T Madison; W P Webster; G D Penick
Journal:  Blood       Date:  1965-12       Impact factor: 22.113

9.  Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis.

Authors:  A M Prince; K Burke
Journal:  Science       Date:  1970-08-07       Impact factor: 47.728

10.  Prophylactic therapy in classical hemophilia: a preliminary report.

Authors:  P M Robinson; P Tittley; R K Smiley
Journal:  Can Med Assoc J       Date:  1967-09-09       Impact factor: 8.262

View more
  2 in total

1.  Twice weekly prophylactic therapy in haemophilia A.

Authors:  A Aronstam; P J Kirk; J McHardy; J W Culver-James; D S McLellan; P Turk; S G Rainsford; M Slattery
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

Review 2.  Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.

Authors:  Omotola O Olasupo; Megan S Lowe; Ashma Krishan; Peter Collins; Alfonso Iorio; Davide Matino
Journal:  Cochrane Database Syst Rev       Date:  2021-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.